Table 2. Oxidative stress evaluation in controls (G1), overweight (G2) and obese subjects (G3).
| G1 (n = 131) | G2 (n = 120) | G3 (n = 79) | G1 X G2* | G1 X G3* | G2 X G3* | |
|---|---|---|---|---|---|---|
| Hydroperoxides (cpm) | 13900 (10740-17010) | 14120 (10950-17350) | 13540 (10250-16260) | NS | NS | NS |
| AOPP (µmol/L) | 127.2 (98.2-174.4) | 159.5 (124.7-230.3) | 195.2 (157.3.257.1) | NS | 0.001 | 0.011 |
| NO (μM) | 25.67 (13.67-40.45) | 13.83 (8.17-42.84) | 12.10 (7.96-27.63) | 0.009 | 0.048 | NS |
| TRAP/UA (μM Trolox/mg/dL) | 177.1 (147.2-207.5) | 158.8 (126.9-190.0) | 138.0 (115.3-164.9) | NS | NS | NS |
AOPP: advanced oxidation protein products; NO: nitric oxide; TRAP: total radical-trapping antioxidant parameter; UA: uric acid; NS: nonsignificant.
*
Adjusted p value for sex and age. AOPP was not significant after adjusting for the presence of MetS, whereas NO maintained its significance.